What do we know about extracellular vesicles causing vascular calcification in cardiovascular disease?
Vascular calcification (VC) is a key process in cardiovascular disease where calcium builds up in artery walls, making them stiff and increasing heart attack risk. Extracellular vesicles (EVs) are tiny particles released by cells that carry proteins, fats, and genetic material. Research shows EVs play a dual role: some drive calcification by delivering pro-calcific signals, while others protect against it by carrying inhibitory molecules. The balance between these types of EVs may determine whether VC progresses.
What the research says
EVs are now recognized as crucial players in VC 3. They are released by vascular smooth muscle cells (VSMCs), endothelial cells, and macrophages. Pro-calcific EVs act as nucleation cores for hydroxyapatite crystal deposition and deliver inflammatory and osteogenic signals, promoting VSMC transformation into bone-like cells 3. A 2023 study in chronic kidney disease (CKD) found that circulating small EVs from CKD patients accelerate VSMC calcification, and blocking EV release with GW4869 nearly reversed aortic calcification in mice 9. The study identified a signature of four microRNAs (miR-126-5p, miR-133, and others) that are depleted in CKD EVs; restoring these miRNAs mitigated calcification 9. On the protective side, EVs can deliver inhibitory microRNAs (e.g., miR-126-5p, miR-133) and proteins like matrix Gla protein to antagonize osteogenic signaling and maintain vascular homeostasis 3. The progress of VC depends on the balance between pro-calcific and anti-calcific EVs 3. Additionally, a 2021 review highlighted that intercellular communication via EVs is a key mechanism in CKD-related VC, alongside mineral dysregulation and inflammation 11. Emerging therapies are exploring EV-based delivery: a 2023 study used grapefruit-derived EVs loaded with sodium thiosulfate and modified with a bone-targeting peptide to inhibit VC in mice by promoting anti-inflammatory macrophage polarization and suppressing osteogenic transformation 10.
What to ask your doctor
- Could my kidney function or other conditions be affecting the balance of extracellular vesicles that promote or prevent vascular calcification?
- Are there any blood tests that measure EV-related markers to assess my risk of vascular calcification?
- What lifestyle changes or medications might help shift the balance toward protective EVs?
- Should I be aware of any ongoing clinical trials using EV-based therapies for vascular calcification?
- How does my current treatment plan address the underlying mechanisms of vascular calcification, such as inflammation or mineral imbalance?
This question is drawn from common patient questions about this topic and answered using cited medical research. We do not provide individualized advice.